AGGF1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "AGGF1" in English language version.

refsWebsite

Global rank English rank

30nih.gov

4^th place

16doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1harvard.edu

18^th place

17^th place

doi.org

Hu Y, Li L, Seidelmann SB, Timur AA, Shen PH, Driscoll DJ, Wang QK (September 2008). "Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program". Annals of Human Genetics. 72 (Pt 5): 636–43. doi:10.1111/j.1469-1809.2008.00458.x. PMC 2602961. PMID 18564129.
Gutierrez S, Magano L, Delicado A, Mori MA, de Torres ML, Fernández L, Palomares M, Fernández E, Tarduchy GR, Molano J, Gracia R, Pajares IL, Lapunzina P (December 2006). "The G397A (E133K) change in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the Spanish population". American Journal of Medical Genetics. Part A. 140 (24): 2832–3. doi:10.1002/ajmg.a.31532. PMID 17103452. S2CID 19068189.
Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E (April 2016). "Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions". Acta Histochemica et Cytochemica. 49 (2): 75–81. doi:10.1267/ahc.15035. PMC 4858542. PMID 27222614.
Zhang T, Yao Y, Wang J, Li Y, He P, Pasupuleti V, Hu Z, Jia X, Song Q, Tian XL, Hu C, Chen Q, Wang QK (December 2016). "Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin". Human Molecular Genetics. 25 (23): 5094–5110. doi:10.1093/hmg/ddw273. PMC 6078640. PMID 27522498.
Li L, Chen D, Li J, Wang X, Wang N, Xu C, Wang QK (January 2014). "Aggf1 acts at the top of the genetic regulatory hierarchy in specification of hemangioblasts in zebrafish". Blood. 123 (4): 501–8. doi:10.1182/blood-2013-07-514612. PMC 3901065. PMID 24277077.
Yao HH, Wang BJ, Wu Y, Huang Q (2017). "High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer". Medical Science Monitor. 23: 1286–1294. doi:10.12659/msm.903248. PMC 5362190. PMID 28289272.
Wang W, Li GY, Zhu JY, Huang DB, Zhou HC, Zhong W, Ji CS (April 2015). "Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma". Medical Oncology. 32 (4): 131. doi:10.1007/s12032-015-0574-2. PMID 25796501. S2CID 25099244.
Fan C, Ouyang P, Timur AA, He P, You SA, Hu Y, Ke T, Driscoll DJ, Chen Q, Wang QK (August 2009). "Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function". The Journal of Biological Chemistry. 284 (35): 23331–43. doi:10.1074/jbc.M109.036079. PMC 2749107. PMID 19556247.
Liu Y, Yang H, Song L, Li N, Han QY, Tian C, Gao E, Du J, Xia YL, Li HH (August 2014). "AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis". Apoptosis. 19 (8): 1254–68. doi:10.1007/s10495-014-1001-4. PMID 24893993. S2CID 7164539.
Zhou B, Zeng S, Li L, Fan Z, Tian W, Li M, Xu H, Wu X, Fang M, Xu Y (June 2016). "Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862 (6): 1203–13. doi:10.1016/j.bbadis.2016.02.002. PMID 26850475.
Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (February 2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. Bibcode:2004Natur.427..640T. doi:10.1038/nature02320. PMC 1618873. PMID 14961121.
Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK (June 2017). "Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury". Journal of the American Heart Association. 6 (6): e005889. doi:10.1161/JAHA.117.005889. PMC 5669188. PMID 28649088.
Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK (August 2016). "Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease". PLOS Biology. 14 (8): e1002529. doi:10.1371/journal.pbio.1002529. PMC 4981375. PMID 27513923.
Chen D, Li L, Tu X, Yin Z, Wang Q (March 2013). "Functional characterization of Klippel-Trenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis". Human Molecular Genetics. 22 (5): 963–76. doi:10.1093/hmg/dds501. PMID 23197652.
Xu W, Zeng S, Li M, Fan Z, Zhou B (September 2017). "Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription". Journal of Biomedical Research. 31 (5): 428–436. doi:10.7555/JBR.30.20160046. PMC 5706435. PMID 28958996.
Barker KT, Foulkes WD, Schwartz CE, Labadie C, Monsell F, Houlston RS, Harper J (July 2006). "Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes?". Journal of Medical Genetics. 43 (7): 613–4. doi:10.1136/jmg.2006.040790. PMC 2564558. PMID 16443853.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000164252 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000021681 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (February 2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. Bibcode:2004Natur.427..640T. doi:10.1038/nature02320. PMC 1618873. PMID 14961121.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hu Y, Li L, Seidelmann SB, Timur AA, Shen PH, Driscoll DJ, Wang QK (September 2008). "Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program". Annals of Human Genetics. 72 (Pt 5): 636–43. doi:10.1111/j.1469-1809.2008.00458.x. PMC 2602961. PMID 18564129.
Gutierrez S, Magano L, Delicado A, Mori MA, de Torres ML, Fernández L, Palomares M, Fernández E, Tarduchy GR, Molano J, Gracia R, Pajares IL, Lapunzina P (December 2006). "The G397A (E133K) change in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the Spanish population". American Journal of Medical Genetics. Part A. 140 (24): 2832–3. doi:10.1002/ajmg.a.31532. PMID 17103452. S2CID 19068189.
Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E (April 2016). "Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions". Acta Histochemica et Cytochemica. 49 (2): 75–81. doi:10.1267/ahc.15035. PMC 4858542. PMID 27222614.
Zhang T, Yao Y, Wang J, Li Y, He P, Pasupuleti V, Hu Z, Jia X, Song Q, Tian XL, Hu C, Chen Q, Wang QK (December 2016). "Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin". Human Molecular Genetics. 25 (23): 5094–5110. doi:10.1093/hmg/ddw273. PMC 6078640. PMID 27522498.
Li L, Chen D, Li J, Wang X, Wang N, Xu C, Wang QK (January 2014). "Aggf1 acts at the top of the genetic regulatory hierarchy in specification of hemangioblasts in zebrafish". Blood. 123 (4): 501–8. doi:10.1182/blood-2013-07-514612. PMC 3901065. PMID 24277077.
Yao HH, Wang BJ, Wu Y, Huang Q (2017). "High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer". Medical Science Monitor. 23: 1286–1294. doi:10.12659/msm.903248. PMC 5362190. PMID 28289272.
Wang W, Li GY, Zhu JY, Huang DB, Zhou HC, Zhong W, Ji CS (April 2015). "Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma". Medical Oncology. 32 (4): 131. doi:10.1007/s12032-015-0574-2. PMID 25796501. S2CID 25099244.
Fan C, Ouyang P, Timur AA, He P, You SA, Hu Y, Ke T, Driscoll DJ, Chen Q, Wang QK (August 2009). "Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function". The Journal of Biological Chemistry. 284 (35): 23331–43. doi:10.1074/jbc.M109.036079. PMC 2749107. PMID 19556247.
Liu Y, Yang H, Song L, Li N, Han QY, Tian C, Gao E, Du J, Xia YL, Li HH (August 2014). "AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis". Apoptosis. 19 (8): 1254–68. doi:10.1007/s10495-014-1001-4. PMID 24893993. S2CID 7164539.
Zhou B, Zeng S, Li L, Fan Z, Tian W, Li M, Xu H, Wu X, Fang M, Xu Y (June 2016). "Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862 (6): 1203–13. doi:10.1016/j.bbadis.2016.02.002. PMID 26850475.
Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (February 2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. Bibcode:2004Natur.427..640T. doi:10.1038/nature02320. PMC 1618873. PMID 14961121.
Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK (June 2017). "Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury". Journal of the American Heart Association. 6 (6): e005889. doi:10.1161/JAHA.117.005889. PMC 5669188. PMID 28649088.
Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK (August 2016). "Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease". PLOS Biology. 14 (8): e1002529. doi:10.1371/journal.pbio.1002529. PMC 4981375. PMID 27513923.
Chen D, Li L, Tu X, Yin Z, Wang Q (March 2013). "Functional characterization of Klippel-Trenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis". Human Molecular Genetics. 22 (5): 963–76. doi:10.1093/hmg/dds501. PMID 23197652.
Xu W, Zeng S, Li M, Fan Z, Zhou B (September 2017). "Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription". Journal of Biomedical Research. 31 (5): 428–436. doi:10.7555/JBR.30.20160046. PMC 5706435. PMID 28958996.
Barker KT, Foulkes WD, Schwartz CE, Labadie C, Monsell F, Houlston RS, Harper J (July 2006). "Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes?". Journal of Medical Genetics. 43 (7): 613–4. doi:10.1136/jmg.2006.040790. PMC 2564558. PMID 16443853.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Hu Y, Li L, Seidelmann SB, Timur AA, Shen PH, Driscoll DJ, Wang QK (September 2008). "Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program". Annals of Human Genetics. 72 (Pt 5): 636–43. doi:10.1111/j.1469-1809.2008.00458.x. PMC 2602961. PMID 18564129.
"Entrez Gene: AGGF1 angiogenic factor with G patch and FHA domains 1".
Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E (April 2016). "Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions". Acta Histochemica et Cytochemica. 49 (2): 75–81. doi:10.1267/ahc.15035. PMC 4858542. PMID 27222614.
Zhang T, Yao Y, Wang J, Li Y, He P, Pasupuleti V, Hu Z, Jia X, Song Q, Tian XL, Hu C, Chen Q, Wang QK (December 2016). "Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin". Human Molecular Genetics. 25 (23): 5094–5110. doi:10.1093/hmg/ddw273. PMC 6078640. PMID 27522498.
Li L, Chen D, Li J, Wang X, Wang N, Xu C, Wang QK (January 2014). "Aggf1 acts at the top of the genetic regulatory hierarchy in specification of hemangioblasts in zebrafish". Blood. 123 (4): 501–8. doi:10.1182/blood-2013-07-514612. PMC 3901065. PMID 24277077.
Yao HH, Wang BJ, Wu Y, Huang Q (2017). "High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer". Medical Science Monitor. 23: 1286–1294. doi:10.12659/msm.903248. PMC 5362190. PMID 28289272.
Fan C, Ouyang P, Timur AA, He P, You SA, Hu Y, Ke T, Driscoll DJ, Chen Q, Wang QK (August 2009). "Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function". The Journal of Biological Chemistry. 284 (35): 23331–43. doi:10.1074/jbc.M109.036079. PMC 2749107. PMID 19556247.
Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (February 2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. Bibcode:2004Natur.427..640T. doi:10.1038/nature02320. PMC 1618873. PMID 14961121.
Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK (June 2017). "Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury". Journal of the American Heart Association. 6 (6): e005889. doi:10.1161/JAHA.117.005889. PMC 5669188. PMID 28649088.
Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK (August 2016). "Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease". PLOS Biology. 14 (8): e1002529. doi:10.1371/journal.pbio.1002529. PMC 4981375. PMID 27513923.
Xu W, Zeng S, Li M, Fan Z, Zhou B (September 2017). "Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription". Journal of Biomedical Research. 31 (5): 428–436. doi:10.7555/JBR.30.20160046. PMC 5706435. PMID 28958996.
Barker KT, Foulkes WD, Schwartz CE, Labadie C, Monsell F, Houlston RS, Harper J (July 2006). "Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes?". Journal of Medical Genetics. 43 (7): 613–4. doi:10.1136/jmg.2006.040790. PMC 2564558. PMID 16443853.

semanticscholar.org

api.semanticscholar.org

Gutierrez S, Magano L, Delicado A, Mori MA, de Torres ML, Fernández L, Palomares M, Fernández E, Tarduchy GR, Molano J, Gracia R, Pajares IL, Lapunzina P (December 2006). "The G397A (E133K) change in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the Spanish population". American Journal of Medical Genetics. Part A. 140 (24): 2832–3. doi:10.1002/ajmg.a.31532. PMID 17103452. S2CID 19068189.
Wang W, Li GY, Zhu JY, Huang DB, Zhou HC, Zhong W, Ji CS (April 2015). "Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma". Medical Oncology. 32 (4): 131. doi:10.1007/s12032-015-0574-2. PMID 25796501. S2CID 25099244.
Liu Y, Yang H, Song L, Li N, Han QY, Tian C, Gao E, Du J, Xia YL, Li HH (August 2014). "AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis". Apoptosis. 19 (8): 1254–68. doi:10.1007/s10495-014-1001-4. PMID 24893993. S2CID 7164539.